Skip to menu Skip to content Skip to footer

2018

Journal Article

Evaluation of a bone morphogenetic protein 6 variant as a cause of iron loading

McDonald, Cameron J., Rishi, Gautam, Secondes, Eriza S., Ostini, Lesa, Wallace, Daniel F., Crawford, Darrell H. G., Sia, Hanlon, Clark, Paul and Subramaniam, V. Nathan (2018). Evaluation of a bone morphogenetic protein 6 variant as a cause of iron loading. Human Genomics, 12 (1) 23, 23. doi: 10.1186/s40246-018-0155-5

Evaluation of a bone morphogenetic protein 6 variant as a cause of iron loading

2018

Journal Article

Bilirubin acts as a multi-potent guardian of cardiovascular integrity: more than just a radical idea

Bulmer, Andrew Cameron, Bakrania, Bhavisha A., Du Toit, Eugene Francois, Boon, Ai-Ching, Clark, Paul J., Powell, Lawrie W., Wagner, Karl-Heinz and Headrick, John P. (2018). Bilirubin acts as a multi-potent guardian of cardiovascular integrity: more than just a radical idea. American Journal of Physiology. Heart and Circulatory Physiology , 315 (3) ajpheart.00417.2017, H429-H447. doi: 10.1152/ajpheart.00417.2017

Bilirubin acts as a multi-potent guardian of cardiovascular integrity: more than just a radical idea

2018

Journal Article

Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life survey

Gill, Jennifer, Baiceanu, Andrei, Clark, Paul J., Langford, Andrew, Latiff, Julianah, Yang, Pei-Ming, Yoshida, Eric M. and Kanavos, Panos (2018). Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life survey. Future Oncology, 14 (17) fon-2017-0715, 1701-1710. doi: 10.2217/fon-2017-0715

Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life survey

2018

Journal Article

More needs to be spent on hepatitis C treatment, not less

Clark, Paul J., Muranushi, Chiho and Hollingworth, Samantha A. (2018). More needs to be spent on hepatitis C treatment, not less. Internal Medicine Journal, 48 (3), 364-366. doi: 10.1111/imj.13718

More needs to be spent on hepatitis C treatment, not less

2018

Journal Article

Projections of primary liver cancer to 2030 in 30 countries worldwide

Valery, Patricia C., Laversanne, Mathieu, Clark, Paul J., Petrick, Jessica L., McGlynn, Katherine A. and Bray, Freddie (2018). Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology, 67 (2), 600-611. doi: 10.1002/hep.29498

Projections of primary liver cancer to 2030 in 30 countries worldwide

2017

Journal Article

Hepatitis C in Australia — a role for general practitioners?

van Driel, Mieke L., Lim, David and Clark, Paul J. (2017). Hepatitis C in Australia — a role for general practitioners?. Medical Journal of Australia, 207 (2), 53-53.e1. doi: 10.5694/mja17.00323

Hepatitis C in Australia — a role for general practitioners?

2017

Journal Article

Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia

Valery, Patricia C., Clark, Paul J., McPhail, Steven M., Rahman, Tony, Hayward, Kelly, Martin, Jennifer, Horsfall, Leigh, Volk, Michael L., Skoien, Richard and Powell, Elizabeth (2017). Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia. Internal Medicine Journal, 47 (4), 429-435. doi: 10.1111/imj.13380

Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia

2016

Journal Article

Use of telehealth to treat and manage chronic viral hepatitis in regional Queensland

Keogh, Kandice, Clark, Paul, Valery, Patricia C., McPhail, Steven M., Bradshaw, Candise, Day, Melany and Smith, Anthony C. (2016). Use of telehealth to treat and manage chronic viral hepatitis in regional Queensland. Journal of Telemedicine and Telecare, 22 (8), 459-464. doi: 10.1177/1357633X16673794

Use of telehealth to treat and manage chronic viral hepatitis in regional Queensland

2016

Journal Article

Serum markers for hepatocellular carcinoma

Clark, Paul (2016). Serum markers for hepatocellular carcinoma. Clinical Liver Disease, 8 (2), 29-33. doi: 10.1002/cld.565

Serum markers for hepatocellular carcinoma

2016

Journal Article

Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability

von Wulffen, M., Clark, P. J., Macdonald, G. A., Raj, A. S., Kendall, B. J., Powell, E. E., Jones, M. P. and Holtmann, G. (2016). Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability. Alimentary Pharmacology and Therapeutics, 44 (1), 68-77. doi: 10.1111/apt.13657

Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability

2016

Journal Article

Hepatobiliary and pancreatic: acute hepatitis in the setting of chronic Schistosoma mansoni infection and post-praziquantel therapy

Gassiep, Ian, Clark, Paul J., McManus, Don P. and Looke, David L. (2016). Hepatobiliary and pancreatic: acute hepatitis in the setting of chronic Schistosoma mansoni infection and post-praziquantel therapy. Journal of Gastroenterology and Hepatology, 31 (5), 910-910. doi: 10.1111/jgh.13239

Hepatobiliary and pancreatic: acute hepatitis in the setting of chronic Schistosoma mansoni infection and post-praziquantel therapy

2016

Journal Article

Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin

Younossi, Zobair M., Stepanova, Maria, Estep, Michael, Negro, Francesco, Clark, Paul J., Hunt, Sharon, Song, Qinghua, Paulson, Matthew, Stamm, Luisa M., Brainard, Diana M., Subramanian, G. Mani, McHutchison, John G. and Patel, Keyur (2016). Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin. Journal of Hepatology, 64 (1), 29-36. doi: 10.1016/j.jhep.2015.08.027

Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin

2015

Journal Article

Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease

Valery, Patricia C., Powell, Elizabeth, Moses, Neta, Volk, Michael L., McPhail, Steven M., Clark, Paul J. and Martin, Jennifer (2015). Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease. BMJ Open, 5 (4) e007451, 1-16. doi: 10.1136/bmjopen-2014-007451

Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease

2015

Journal Article

Remoteness, race and social disadvantage: Disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia

Clark, Paul J., Stuart, Katherine A., Leggett, Barbara A., Crawford, Darrell H., Boyd, Peter, Fawcett, Jonathan, Whiteman, David C. and Baade, Peter D. (2015). Remoteness, race and social disadvantage: Disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia. Liver International, 35 (12), 2584-2594. doi: 10.1111/liv.12853

Remoteness, race and social disadvantage: Disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia

2014

Journal Article

Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer

Neale, Rachel E., Clark, Paul J., Fawcett, Jonathan, Fritschi, Lin, Nagler, Belinda N., Risch, Harvey A., Walters, Rhiannon J., Crawford, William J., Webb, Penelope M., Whiteman, David C. and Buchanan, Daniel D. (2014). Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer. Cancer Epidemiology, 38 (5), 576-582. doi: 10.1016/j.canep.2014.08.006

Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer

2014

Journal Article

Trends in hepatitis C treatment uptake in the United States

Clark, Paul J., Thompson, Alexander J., Patel, Keyur, Muir, Andrew J. and Volk, Michael L. (2014). Trends in hepatitis C treatment uptake in the United States. Hepatology, 60 (2), 768-769. doi: 10.1002/hep.27213

Trends in hepatitis C treatment uptake in the United States

2014

Journal Article

Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication

Choi, Steve S., Claridge, Lee C., Jhaveri, Ravi, Swiderska-Syn, Marzena, Clark, Paul, Suzuki, Ayako, Pereira, Thiago A., Mi, Zhiyong, Kuo, Paul C., Guy, Cynthia D., Pereira, Fausto E. L., Diehl, Anna Mae, Patel, Keyur and Syn, Wing-Kin (2014). Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication. Clinical Science, 126 (12), 845-855. doi: 10.1042/CS20130473

Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication

2014

Journal Article

The association of Il28b genotype with the histological features of chronic hepatitis C Is HCV genotype dependent

D'Ambrosio, R., Aghemo, A., De Francesco, R., Rumi, M. G., Galmozzi, E., De Nicola, S., Cheroni, C., Clark, P. J., Ronchi, G., Lampertico, P. and Colombo, M. (2014). The association of Il28b genotype with the histological features of chronic hepatitis C Is HCV genotype dependent. International Journal of Molecular Sciences, 15 (5), 7213-7224. doi: 10.3390/ijms15057213

The association of Il28b genotype with the histological features of chronic hepatitis C Is HCV genotype dependent

2014

Journal Article

Enhancing hepatitis C treatment in the custodial setting: a national roadmap. Challenges and opportunities for enhanced services

Mina, Michael M., Clark, Paul J., Beasley, Holly M., Herawati, Lilie, Butler, Tony G. and Lloyd, Andrew R. (2014). Enhancing hepatitis C treatment in the custodial setting: a national roadmap. Challenges and opportunities for enhanced services. Medical Journal of Australia, 200 (1), 15-16. doi: 10.5694/mja13.10654

Enhancing hepatitis C treatment in the custodial setting: a national roadmap. Challenges and opportunities for enhanced services

2014

Journal Article

Recurrence of hepatocellular carcinoma: Importance of mRECIST response to chemoembolization and tumor size

Kim, D. J., Clark, P. J., Heimbach, J., Rosen, C., Sanchez, W., Watt, K. and Charlton, M. R. (2014). Recurrence of hepatocellular carcinoma: Importance of mRECIST response to chemoembolization and tumor size. American Journal of Transplantation, 14 (6), 1383-1390. doi: 10.1111/ajt.12684

Recurrence of hepatocellular carcinoma: Importance of mRECIST response to chemoembolization and tumor size